Overview
Aquestive Therapeutics is a Warren, New Jersey pharmaceutical company that develops medicines delivered through alternatives to invasive standard-of-care administration, using its PharmFilm oral film technology. Its lead candidate is Anaphylm (dibutepinephrine) sublingual film for severe allergic reactions including anaphylaxis; after a January 2026 Complete Response Letter it resubmitted the NDA, which the FDA accepted with a PDUFA goal date of March 16, 2027. Aquestive also manufactures four licensed products marketed by its licensees, and is building a launch sales team.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Aquestive Therapeutics’s careers page.
- Aquestive District Sales ManagerChicago, Illinois +49d ago$180k–$210k
- Aquestive District Sales ManagerNewark, New Jersey +59d ago$180k–$210k
- Aquestive District Sales ManagerHartford, Connecticut +49d ago$180k–$210k
- Aquestive District Sales ManagerOrlando, Florida +49d ago$180k–$210k
- Aquestive District Sales ManagerDenver, Colorado +49d ago$180k–$210k
- Aquestive District Sales ManagerDallas, Texas +49d ago$180k–$210k
Divisions
Division information is pending company verification.Once Aquestive Therapeutics claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Aquestive Therapeutics
These sections fill in when Aquestive Therapeutics claims and verifies its page.